Confessions of a flight attendant

Although the company will continue to pursue “higher-risk, high reward” drug candidates such as pegilodecakin, these will be a smaller part of the portfolio in the future, said Chief Scientific Officer Daniel Skovronsky. Mr Hancock was today accused of ‘sh**ging on the taxpayer’ after it was revealed he took his mistress to…